ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,302.80
      0.03%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      73.605
      -0.38%
      Bitcoin
      63,401.91
      -0.35%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Precigen Inc (PGEN)

      7. Precigen Inc (PGEN) News

      PGEN

      Precigen (PGEN)

      Precigen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PGEN
      DateTimeSourceHeadlineSymbolCompany
      09/16/20244:30PMPR Newswire (US)Precigen to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:PGENPrecigen Inc
      08/30/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
      08/14/20244:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
      08/14/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
      08/14/20244:05PMPR Newswire (US)Precigen Reports Second Quarter and First Half 2024 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
      08/13/20245:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      08/09/20249:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
      08/09/20248:00AMPR Newswire (US)Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14thNASDAQ:PGENPrecigen Inc
      08/08/20244:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PGENPrecigen Inc
      08/07/20249:30PMPR Newswire (US)Precigen Announces Pricing of $30.0 Million Public Offering of Common StockNASDAQ:PGENPrecigen Inc
      08/06/20244:46PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PGENPrecigen Inc
      08/06/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
      08/06/20244:04PMPR Newswire (US)Precigen Announces Proposed $30 Million Public Offering of Common StockNASDAQ:PGENPrecigen Inc
      08/06/20244:01PMPR Newswire (US)Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy LaunchNASDAQ:PGENPrecigen Inc
      07/24/20245:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      07/24/20245:20PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      07/23/20248:01AMPR Newswire (US)Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy LaunchNASDAQ:PGENPrecigen Inc
      06/03/20249:30AMPR Newswire (US)Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete ResponseNASDAQ:PGENPrecigen Inc
      05/31/20247:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      05/31/20247:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      05/31/20247:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      05/31/20247:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      05/31/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
      05/28/20244:48PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PGENPrecigen Inc
      05/28/20244:44PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PGENPrecigen Inc
      05/23/20245:00PMPR Newswire (US)Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
      05/14/20245:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
      05/14/20245:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
      05/14/20244:05PMPR Newswire (US)Precigen Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
      05/08/20244:05PMPR Newswire (US)Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
       Showing the most relevant articles for your search:NASDAQ:PGEN

      Your Recent History

      AMEX
      TMBR
      Timber Pharmaceuticals
      Delayed Upgrade Clock